• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化脂代谢紊乱:一项横断面研究。

Cystic fibrosis dyslipidaemia: A cross-sectional study.

机构信息

Poznan University of Medical Sciences, Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan, Poland.

Poznan University of Medical Sciences, Department of Pediatric Pneumonology, Allergology and Clinical Immunology, Poznan, Poland.

出版信息

J Cyst Fibros. 2019 Jul;18(4):566-571. doi: 10.1016/j.jcf.2019.04.001. Epub 2019 Apr 10.

DOI:10.1016/j.jcf.2019.04.001
PMID:30979683
Abstract

BACKGROUND

The interest in cystic fibrosis (CF) dyslipidaemia as a potential risk factor for cardiovascular disease is increasing with patients' survival. This study aimed to investigate CF dyslipidaemia, its clinical correlates and links to oxidized low-density lipoprotein (oxLDL), adiponectin, and apolipoprotein E (APOE).

METHODS

This cross-sectional study assessed clinical characteristics of CF, as well as the serum lipid profile, oxLDL, adiponectin, and APOE.

RESULTS

In total, 108 CF subjects were enrolled in this study, with a median age of 22 years, BMI of 20.5 kg/m, FEV1% of 61%, of which 81% were pancreatic insufficient (PI). Healthy subjects (HS; n = 51) were in similar age. Hypocholesterolaemia occurred in 31% of CF subjects and in no HS. Hypertriglyceridaemia concerned 21% of patients (HS: 8%, p = .04), and low HDL-C 45% (HS: 6%, p < .0001). At least one of these three CF dyslipidaemia disturbances was present in 62% of CF subjects, but there were no significant differences in oxLDL, oxLDL/LDL-C ratio, adiponectin, and APOE between CF and HS groups. PI was independently associated with low total cholesterol, LDL-C, and non-high density lipoprotein cholesterol, with age and sex also modifying lipid levels. In CF (n = 42), triglycerides did not correlate with serum tumour necrosis factor α (TNF-α).

CONCLUSIONS

CF dyslipidaemia is highly prevalent and heterogenous. The lipid profile weakly associates with the clinical characteristics of CF as well as oxLDL, adiponectin, and APOE. Further research is needed, especially regarding HDL function in CF, the causes of hypertriglyceridaemia, and the value of essential fatty acid supplementation for CF dyslipidaemia.

摘要

背景

随着患者生存时间的延长,囊性纤维化(CF)血脂异常作为心血管疾病潜在风险因素的重要性日益增加。本研究旨在探讨 CF 血脂异常及其临床相关性,并探讨其与氧化型低密度脂蛋白(oxLDL)、脂联素和载脂蛋白 E(APOE)的关系。

方法

本横断面研究评估了 CF 的临床特征,以及血脂谱、oxLDL、脂联素和 APOE。

结果

共纳入 108 例 CF 患者,中位年龄 22 岁,BMI 为 20.5kg/m,FEV1%为 61%,其中 81%为胰腺功能不全(PI)。健康对照者(HS;n=51)年龄相仿。CF 患者中 31%存在低胆固醇血症,而 HS 中则无。CF 患者中 21%存在高甘油三酯血症(HS:8%,p=0.04),45%存在低高密度脂蛋白胆固醇血症(HS:6%,p<0.0001)。CF 患者中至少存在上述三种血脂异常中的一种者占 62%,但 CF 和 HS 组间 oxLDL、oxLDL/LDL-C 比值、脂联素和 APOE 无显著差异。PI 与总胆固醇、LDL-C 和非高密度脂蛋白胆固醇降低独立相关,年龄和性别也可影响血脂水平。在 CF 患者(n=42)中,甘油三酯与血清肿瘤坏死因子-α(TNF-α)无关。

结论

CF 血脂异常十分常见且具有异质性。血脂谱与 CF 的临床特征及 oxLDL、脂联素和 APOE 相关较弱。还需要进一步研究,尤其是关于 CF 中 HDL 功能、高甘油三酯血症的原因以及必需脂肪酸补充对 CF 血脂异常的价值。

相似文献

1
Cystic fibrosis dyslipidaemia: A cross-sectional study.囊性纤维化脂代谢紊乱:一项横断面研究。
J Cyst Fibros. 2019 Jul;18(4):566-571. doi: 10.1016/j.jcf.2019.04.001. Epub 2019 Apr 10.
2
Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.成年囊性纤维化患者尽管存在糖耐异常(或糖尿病)及炎症,但脂联素水平正常。
Diabetes Metab. 2007 Jun;33(3):213-9. doi: 10.1016/j.diabet.2007.01.004. Epub 2007 Apr 5.
3
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.氧化型低密度脂蛋白抗体/高密度脂蛋白胆固醇比值与晚期非酒精性脂肪性肝病瘦患者有关。
J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.
4
Oxidised low-density lipoprotein, a possible distinguishing lipid profile biomolecule between prostate cancer and benign prostatic hyperplasia.氧化型低密度脂蛋白,一种可能区分前列腺癌和良性前列腺增生的脂质特征生物分子。
Andrologia. 2019 Sep;51(8):e13321. doi: 10.1111/and.13321. Epub 2019 May 30.
5
Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?氧化型低密度脂蛋白(oxLDL)血浆水平及其与 LDL 的比值 - 它们是透析患者真正的氧化应激标志物吗?
Life Sci. 2013 Mar 12;92(4-5):253-8. doi: 10.1016/j.lfs.2012.12.002. Epub 2013 Jan 4.
6
Prevalence of dyslipidemia in adults with cystic fibrosis.囊性纤维化成人血脂异常的患病率。
J Cyst Fibros. 2010 Jan;9(1):24-8. doi: 10.1016/j.jcf.2009.09.002. Epub 2009 Oct 29.
7
Evaluation of adipokines in children with cystic fibrosis.评估囊性纤维化患儿的脂肪因子。
Endokrynol Pol. 2018;69(2):128-134. doi: 10.5603/EP.a2018.0007. Epub 2018 Feb 21.
8
Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.多囊卵巢综合征青春期女孩血清瘦素、氧化型低密度脂蛋白和血浆不对称二甲基精氨酸水平及其与血脂异常的关系。
Clin Endocrinol (Oxf). 2007 Jul;67(1):129-34. doi: 10.1111/j.1365-2265.2007.02849.x. Epub 2007 Apr 25.
9
[Diabetic dyslipidaemia and the atherosclerosis].[糖尿病血脂异常与动脉粥样硬化]
Orv Hetil. 2016 May 8;157(19):746-52. doi: 10.1556/650.2016.30441.
10
Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis.
Pediatr Res. 1993 Aug;34(2):162-6. doi: 10.1203/00006450-199308000-00011.

引用本文的文献

1
Genetic Heterogeneity Correlated with Phenotypic Variability in 48 Patients with Cystic Fibrosis.48例囊性纤维化患者的基因异质性与表型变异性的相关性
J Clin Med. 2025 Jul 29;14(15):5362. doi: 10.3390/jcm14155362.
2
Cholesterol and triglyceride concentrations following 12-18 months of clinically prescribed elexacaftor-tezacaftor-ivacaftor-PROMISE sub-study.临床规定的依列卡福-替扎卡福-依伐卡福治疗12 - 18个月后的胆固醇和甘油三酯浓度 - PROMISE子研究
J Clin Transl Endocrinol. 2025 Apr 2;40:100391. doi: 10.1016/j.jcte.2025.100391. eCollection 2025 Jun.
3
New era, new GOALs: cardiovascular screening and lipid management in cystic fibrosis.
新时代,新目标:囊性纤维化的心血管筛查与血脂管理
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251317200. doi: 10.1177/17534666251317200.
4
Impaired intestinal free fatty acid transport followed by chylomicron malformation, not pancreatic insufficiency, cause metabolic defects in cystic fibrosis.肠内游离脂肪酸转运受损,继以乳糜微粒形成异常,而非胰腺功能不全,导致囊性纤维化的代谢缺陷。
J Lipid Res. 2024 Jul;65(7):100551. doi: 10.1016/j.jlr.2024.100551. Epub 2024 Jul 13.
5
An integrated metaproteomics workflow for studying host-microbe dynamics in bronchoalveolar lavage samples applied to cystic fibrosis disease.用于研究支气管肺泡灌洗液样本中宿主-微生物动态的整合宏蛋白质组学工作流程应用于囊性纤维化疾病。
mSystems. 2024 Jul 23;9(7):e0092923. doi: 10.1128/msystems.00929-23. Epub 2024 Jun 27.
6
Calcium, Phosphorus, and Vitamin D Levels in a Series of Cystic Fibrosis Patients: A Cross-Sectional Study.囊性纤维化患者系列中钙、磷和维生素 D 水平:一项横断面研究。
Int J Mol Sci. 2024 Feb 5;25(3):1900. doi: 10.3390/ijms25031900.
7
Alterations in lipids after initiation of highly effective modulators in people with cystic fibrosis.在囊性纤维化患者中起始高效调节剂后脂质的变化。
J Cyst Fibros. 2023 Nov;22(6):1024-1026. doi: 10.1016/j.jcf.2023.10.002. Epub 2023 Oct 12.
8
Changes of androgen and corticosterone metabolites excretion and conversion in cystic fibrosis.囊性纤维化中雄激素和皮质甾酮代谢产物排泄和转化的变化。
Front Endocrinol (Lausanne). 2023 Aug 29;14:1244127. doi: 10.3389/fendo.2023.1244127. eCollection 2023.
9
Future Comorbidities in an Aging Cystic Fibrosis Population.老龄化囊性纤维化人群的未来合并症
Life (Basel). 2023 May 31;13(6):1305. doi: 10.3390/life13061305.
10
Alteration in glucocorticoids secretion and metabolism in patients affected by cystic fibrosis.囊性纤维化患者糖皮质激素分泌和代谢的改变。
Front Endocrinol (Lausanne). 2022 Dec 8;13:1074209. doi: 10.3389/fendo.2022.1074209. eCollection 2022.